Common Contracts
3 similar Underwriting Agreement contracts by Idenix Pharmaceuticals Inc, Luminex Corp, Raymond James Financial Inc
RAYMOND JAMES FINANCIAL, INC. UNDERWRITING AGREEMENT SHARES OF PREFERRED STOCKUnderwriting Agreement • May 24th, 2012 • Raymond James Financial Inc • Security brokers, dealers & flotation companies • New York
Raymond James Financial, Inc., a Florida corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule II hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), shares (the “[Firm] Shares”) of preferred stock, Series [ ], [$0.10] par value, with a liquidation preference of [$ ] per share (the “Preferred Stock”). [In addition, the Company proposes to grant to the Underwriters an option to purchase from the Company up to an aggregate of additional shares of Preferred Stock (the “Option Shares”). The Firm Shares and the Option Shares are herein referred to as the “Shares”.] Such Shares are to be sold to each Underwriter, acting severally and not jointly, in such amounts as are listed in Schedule II opposite the name of each Underwriter. The Shares are described more fully in the Prospectus, referred to below. If the firm or firms listed in Schedule II hereto include only the firm or firms listed in Schedule I hereto
IDENIX PHARMACEUTICALS, INC. 18,310,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • April 11th, 2011 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by J.P. Morgan Securities LLC (the “Underwriter”), of common stock, $0.001 par value, of the Company (the “Securities”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.
UBS SECURITIES LLC LUMINEX CORPORATION 3,500,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • June 25th, 2008 • Luminex Corp • Services-commercial physical & biological research • New York
Luminex Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are collectively herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights are to be issued pursuant to a Rights Agreement (the “Rights Agreement”) dated as of June 20, 2001 betw
